Soluble urokinase plasminogen activator receptor (suPAR) predicts 1 year mortality in patients with acute breathlessness

被引:0
|
作者
Chew-Harris, J. S. [1 ]
Appleby, S. [1 ]
Richards, A. M. [1 ]
Troughton, R. W. [1 ]
Pemberton, C. J. [1 ]
机构
[1] Univ Otago Christchurch, Med, Christchurch, New Zealand
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P2616
引用
收藏
页码:1573 / 1573
页数:1
相关论文
共 50 条
  • [1] Soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in exacerbated COPD
    Jorgensen, Ditte Vendelbo
    Godtfredsen, Nina Skalvan
    Marsaa, Kristoffer
    Ulrik, Charlotte Suppli
    Andersen, Ove
    Eugen-Olsen, Jesper
    Rasmussen, Line Jee Hartmann
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [2] Prognostic performance of soluble urokinase plasminogen activator receptor for 1-year mortality in Asian and Western patients with acute breathlessness
    Chew-Harris, J.
    Appleby, S.
    Kuan, W. S.
    Ibrahim, I.
    Chan, S. P.
    Li, Z.
    Liew, O. W.
    Frampton, C.
    Troughton, R. W.
    Chong, J. P. C.
    Tan, L. L.
    Lin, W.
    OOi, S. B. S.
    Richards, A. M.
    Pemberton, C. J.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1202 - 1202
  • [3] Soluble urokinase type plasminogen activator receptor (suPAR) and mortality in acute pulmonary embolism
    Oblitas, Crhistian-Mario
    Lopez-Rubio, Marina
    Lago-Rodriguez, Marta-Olimpia
    Galeano-Valle, Francisco
    Garcia-Gamiz, Mercedes
    Zamora-Trillo, Angielys
    Walther, Luis-Antonio Alvarez-Sala
    Demelo-Rodriguez, Pablo
    MEDICINA CLINICA, 2024, 163 (06): : 281 - 285
  • [4] Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia
    T. Mölkänen
    E. Ruotsalainen
    C. W. Thorball
    A. Järvinen
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 1417 - 1424
  • [5] Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia
    Molkanen, T.
    Ruotsalainen, E.
    Thorball, C. W.
    Jarvinen, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (11) : 1417 - 1424
  • [6] Soluble urokinase plasminogen activator receptor (suPAR) predicts 2-year cardiovascular events in patients after acute chest pain
    Chew-Harris, J.
    Appleby, S.
    Troughton, R. W.
    Richards, A. M.
    Pemberton, C. J.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1696 - 1696
  • [7] Soluble urokinase plasminogen activator receptor (suPAR) is associatedwith COPD readmission and mortality
    Hakansson, Kjell Erik Julius
    Ulrik, Charlotte Suppli
    Godtfredsen, Nina Skavlan
    Kallemose, Thomas
    Andersen, Ove
    Eugen-Olsen, Jesper
    Marsaa, Kristoffer
    Rasmussen, Line J. H.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [8] Soluble urokinase plasminogen activator receptor (suPAR) predicts hospital readmissions and all-cause mortality in patients admitted with asthma
    Hakansson, Kjell Erik Julius
    Rasmussen, Line J. H.
    Godtfredsen, Nina S.
    Tupper, Oliver Djurhuus
    Eugen-Olsen, Jesper
    Kallemose, Thomas
    Andersen, Ove
    Marsaa, Kristoffer
    Ulrik, Charlotte S.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [9] Urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) serum level in patients with malignant lymphomas
    Hus, I
    Cioch, M
    Jawniak, D
    Manko, J
    Dmoszynska, A
    Chrapko, M
    Hus, M
    BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY, 2002, : 141 - 144
  • [10] Soluble urokinase plasminogen activator receptor (suPAR) promotes atherosclerosis
    Drueke, Tilman B.
    Massy, Ziad A.
    KIDNEY INTERNATIONAL, 2023, 103 (03) : 451 - 454